Mike Matson
Stock Analyst at Needham
(2.35)
# 2,465
Out of 5,182 analysts
550
Total ratings
41.23%
Success rate
-0.21%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Buy | $58 → $44 | $25.41 | +73.16% | 23 | May 8, 2026 | |
| TMDX TransMedics Group | Maintains: Buy | $174 → $142 | $67.84 | +109.32% | 16 | May 6, 2026 | |
| SYK Stryker | Maintains: Buy | $454 → $418 | $285.47 | +46.43% | 12 | May 1, 2026 | |
| MMSI Merit Medical Systems | Maintains: Buy | $101 → $90 | $61.27 | +46.89% | 35 | May 1, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $97 → $77 | $53.93 | +42.78% | 38 | Apr 23, 2026 | |
| VCYT Veracyte | Maintains: Buy | $48 | $40.42 | +18.75% | 20 | Apr 1, 2026 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.03 | +191.26% | 23 | Mar 26, 2026 | |
| MDT Medtronic | Reiterates: Buy | $120 | $76.15 | +57.58% | 25 | Mar 26, 2026 | |
| KIDS OrthoPediatrics | Maintains: Buy | $26 → $30 | $17.81 | +68.44% | 25 | Feb 27, 2026 | |
| PSNL Personalis | Maintains: Buy | $10 → $12 | $5.98 | +100.67% | 22 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $26.52 | +96.08% | 17 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $147 | $133.06 | +10.48% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $81 | $71.86 | +12.72% | 28 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $86 | $71.77 | +19.83% | 7 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $8.96 | +67.41% | 29 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $26.28 | +71.23% | 36 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $82.33 | - | 27 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $36.76 | - | 26 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $322.23 | - | 14 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $55.12 | - | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.25 → $9 | $5.01 | +79.64% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $13.96 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $7.02 | +70.94% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $178.31 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $126.43 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $207.45 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $206.76 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $12.27 | +242.30% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $77.95 | -3.78% | 1 | Feb 18, 2021 |
Artivion
May 8, 2026
Maintains: Buy
Price Target: $58 → $44
Current: $25.41
Upside: +73.16%
TransMedics Group
May 6, 2026
Maintains: Buy
Price Target: $174 → $142
Current: $67.84
Upside: +109.32%
Stryker
May 1, 2026
Maintains: Buy
Price Target: $454 → $418
Current: $285.47
Upside: +46.43%
Merit Medical Systems
May 1, 2026
Maintains: Buy
Price Target: $101 → $90
Current: $61.27
Upside: +46.89%
Boston Scientific
Apr 23, 2026
Maintains: Buy
Price Target: $97 → $77
Current: $53.93
Upside: +42.78%
Veracyte
Apr 1, 2026
Maintains: Buy
Price Target: $48
Current: $40.42
Upside: +18.75%
Lucid Diagnostics
Mar 26, 2026
Reiterates: Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
Medtronic
Mar 26, 2026
Reiterates: Buy
Price Target: $120
Current: $76.15
Upside: +57.58%
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $26 → $30
Current: $17.81
Upside: +68.44%
Personalis
Feb 27, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $5.98
Upside: +100.67%
Feb 26, 2026
Maintains: Buy
Price Target: $49 → $52
Current: $26.52
Upside: +96.08%
Feb 26, 2026
Maintains: Buy
Price Target: $138 → $147
Current: $133.06
Upside: +10.48%
Feb 25, 2026
Maintains: Buy
Price Target: $64 → $81
Current: $71.86
Upside: +12.72%
Feb 24, 2026
Maintains: Buy
Price Target: $84 → $86
Current: $71.77
Upside: +19.83%
Feb 17, 2026
Maintains: Buy
Price Target: $14 → $15
Current: $8.96
Upside: +67.41%
Feb 12, 2026
Reiterates: Buy
Price Target: $45
Current: $26.28
Upside: +71.23%
Feb 10, 2026
Reiterates: Hold
Price Target: n/a
Current: $82.33
Upside: -
Jan 29, 2026
Reiterates: Hold
Price Target: n/a
Current: $36.76
Upside: -
Jan 16, 2026
Downgrades: Hold
Price Target: n/a
Current: $322.23
Upside: -
Dec 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $55.12
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $5.01
Upside: +79.64%
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $13.96
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $7.02
Upside: +70.94%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $178.31
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $126.43
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $207.45
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $206.76
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $12.27
Upside: +242.30%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $77.95
Upside: -3.78%